Anondita Medicare Q4 FY26 results (Jan–Mar 2026) and concall

Anondita Medicare Ltd delivered exceptional financial results for H2 and FY26, marked by significant revenue and profit growth driven by capacity expansion and strategic international market entry. The company achieved crucial certifications and pioneered female condom registration in Brazil. While growth was robust, management acknowledged challenges in working capital management and an increase in other expenses, with plans to mitigate these through an increased focus on export markets.